Gentronix and Apredica to Create Predictive-Toxicology Service

Gentronix and Apredica have announced a strategic alliance to provide drug-discovery support services in the area of predictive toxicology.

The objective of the alliance is to reduce the failure rate of drugs in late development, particularly due to toxicity, thereby improving the efficiency of drug discovery and increasing the assurance that new drugs are safe.